Edmund Dunn - 04 Mar 2026 Form 4 Insider Report for Monte Rosa Therapeutics, Inc. (GLUE)

Role: Principal Accounting Officer
Signature: /s/ Phil Nickson, Attorney-in-Fact
Issuer symbol: GLUE
Transactions as of: 04 Mar 2026
Net transactions value: -$2,496
Form type: 4
Filing time: 05 Mar 2026, 17:24:23 UTC
Previous filing: 02 Mar 2026
SEC: View on sec.gov

Reporting Owners (1)

Name	Relationship	Address	Signature	Signature date	CIK
Dunn Edmund	Principal Accounting Officer	MONTE ROSA THERAPEUTICS, INC., 321 HARRISON AVENUE, SUITE 900, BOSTON	/s/ Phil Nickson, Attorney-in-Fact	05 Mar 2026	0001989401

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	GLUE	Common Stock	Sale	$2,496	-139	-0.61%	$17.96	22,554	04 Mar 2026	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Represents shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units. These sales were automatic and not in the discretion of the Reporting Person.